The Role of Chronic Inflammation in Pediatric Cancer
Christine Mella,
No information about this author
Panogiotis Tsarouhas,
No information about this author
Maximillian Brockwell
No information about this author
et al.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(1), P. 154 - 154
Published: Jan. 6, 2025
Inflammation
plays
a
crucial
role
in
wound
healing
and
the
host
immune
response
following
pathogenic
invasion.
However,
unresolved
chronic
inflammation
can
result
tissue
fibrosis
genetic
alterations
that
contribute
to
pathogenesis
of
human
diseases
such
as
cancer.
Recent
scientific
advancements
exploring
underlying
mechanisms
malignant
cellular
transformations
cancer
progression
have
exposed
significant
disparities
between
pediatric
adult-onset
cancers.
For
instance,
cancers
tend
lower
mutational
burdens
arise
actively
developing
tissues,
where
cell-cycle
dysregulation
leads
gene,
chromosomal,
fusion
gene
development
not
seen
counterparts.
As
such,
findings
adult
cannot
be
directly
applied
cancers,
unique
mutations
inherent
etiologies
remain
poorly
understood.
Here,
we
review
processes
chromosomal
instability,
tumor
microenvironment,
tumorigenesis
transformation
explore
current
therapeutic
interventions
maintain
and/or
restore
inflammatory
homeostasis.
Language: Английский
Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis
Mengchao YANG,
No information about this author
Yufeng Mu,
No information about this author
Xiaoyun Yu
No information about this author
et al.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
176, P. 116783 - 116783
Published: May 25, 2024
During
tumor
development,
the
itself
must
continuously
generate
new
blood
vessels
to
meet
their
growth
needs
while
also
allowing
for
invasion
and
metastasis.
One
of
most
common
features
tumors
is
hypoxia,
which
drives
process
angiogenesis
by
regulating
microenvironment,
thus
adversely
affecting
prognosis
patients.
In
addition,
overcome
unsuitable
environments
growth,
such
as
nutrient
deficiency,
hyperacidity,
immunosuppression,
microenvironment
(TME)
coordinates
in
several
ways
restore
supply
oxygen
nutrients
remove
metabolic
wastes.
A
growing
body
research
suggests
that
hypoxia
interact
through
a
complex
interplay
crosstalk,
inextricably
linked
TME.
Here,
we
review
TME's
positive
contribution
from
an
angiogenesis-centric
perspective
considering
objective
impact
hypoxic
phenotypes
status
limitations
current
angiogenic
therapies.
Language: Английский
Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments
Ahmad Dawalibi,
No information about this author
Amal Alosaimi,
No information about this author
Khalid S. Mohammad
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(15), P. 8163 - 8163
Published: July 26, 2024
Bone
metastases,
a
common
and
debilitating
consequence
of
advanced
cancers,
involve
complex
interplay
between
malignant
cells
the
bone
microenvironment.
Central
to
this
interaction
are
interleukins
(ILs),
group
cytokines
with
critical
roles
in
immune
modulation
inflammation.
This
review
explores
dualistic
nature
pro-inflammatory
anti-inflammatory
emphasizing
their
molecular
mechanisms,
pathological
impacts,
therapeutic
potential.
Pro-inflammatory
interleukins,
such
as
IL-1,
IL-6,
IL-8,
have
been
identified
key
drivers
promoting
osteoclastogenesis,
tumor
proliferation,
angiogenesis.
These
create
favorable
environment
for
cancer
cell
survival
degradation,
contributing
progression
metastatic
lesions.
Conversely,
including
IL-4,
IL-10,
IL-13,
exhibit
protective
by
modulating
responses
inhibiting
osteoclast
activity.
Understanding
these
opposing
effects
is
crucial
developing
targeted
therapies
aimed
at
disrupting
processes
metastases.
Key
signaling
pathways,
NF-κB,
JAK/STAT,
MAPK,
mediate
actions
influencing
survival,
recruitment,
remodeling.
Targeting
pathways
presents
promising
avenues.
Current
treatment
strategies,
use
denosumab,
tocilizumab,
emerging
agents
like
bimekizumab
ANV419,
highlight
potential
interleukin-targeted
mitigating
However,
challenges
resistance,
side
effects,
long-term
efficacy
remain
significant
hurdles.
also
addresses
diagnostic
prognostic
biomarkers,
offering
insights
into
patient
stratification
personalized
approaches.
Interleukins
multifaceted
that
depend
on
context,
environment,
types,
cellular
interactions.
Despite
substantial
progress,
gaps
research
persist,
particularly
regarding
precise
mechanisms
which
influence
niche
broader
clinical
implications.
While
not
exhaustive,
overview
underscores
metastases
highlights
need
continued
fully
elucidate
interactions
Addressing
will
be
essential
advancing
our
understanding
patients.
Language: Английский
IL-1 Superfamily Across 400+ Species: Therapeutic Targets and Disease Implications
Wei‐Bin Wang,
No information about this author
Dawei Li,
No information about this author
Kaiyong Luo
No information about this author
et al.
Biology,
Journal Year:
2025,
Volume and Issue:
14(5), P. 561 - 561
Published: May 17, 2025
An
important
area
of
interest
for
therapeutic
development
is
the
IL-1
superfamily,
a
critical
group
immune
regulators
with
profound
implications
in
variety
disorders.
This
study
clarifies
evolutionary
patterns
family
members
by
thoroughly
analyzing
more
than
400
animal
species,
demonstrating
their
ancient
roots
that
extend
back
to
earliest
vertebrates.
Important
results
show
that,
although
ligands
expanded
significantly
over
evolution
mammals,
corresponding
receptors
remained
remarkably
structurally
conserved.
Identifying
both
lineage-specific
adaptations
and
evolutionarily
conserved
residues
provides
vital
information
treatment
design.
These
findings
point
possibility
two
different
strategies:
addressing
species-specific
variants
may
allow
targeted
interventions,
whereas
focusing
on
motifs
result
broad-acting
treatments.
The
also
identified
less
well-known
species
as
useful
models
comprehending
early
systems.
In
addition
advancing
our
knowledge
function
autoimmune,
inflammatory,
carcinogenic
illnesses,
this
research
lays
groundwork
potent
therapeutics
creating
an
framework
family.
Language: Английский
Characterization of the malignant cells and microenvironment of infantile fibrosarcoma via single-cell RNA sequencing
Yi Li,
No information about this author
Qingchi Zhang,
No information about this author
Ran Yang
No information about this author
et al.
Translational Pediatrics,
Journal Year:
2024,
Volume and Issue:
13(4), P. 596 - 609
Published: April 1, 2024
Background:
Infantile
fibrosarcoma
(IFS)
is
the
most
prevalent
soft
tissue
sarcoma
in
children
under
1
year
old
and
known
for
its
rapid
growth.
The
tumor
lacks
specific
immunohistochemical
marker
a
general
view
of
microenvironment
(TME).
Its
primary
therapeutic
intervention
places
patients
at
risk
disability
or
mutilation.
This
study
aimed
to
elucidate
universal
transcriptional
characteristics
IFS
explore
novel
targets
diagnosis
therapy
using
single-cell
RNA
sequencing
(scRNA-seq).
Methods:
Fresh
samples
scRNA-seq
were
collected
from
four
before
other
treatments
administered.
We
conducted
cell
clustering,
inferring
copy
number
variation
(InferCNV)
analysis,
gene
differential
expression
function
evaluation,
Pearson
correlation
cell-cell
ligand-receptor
interaction
analysis
investigate
distinct
ecosystem
IFS.
Results:
According
resolution
data,
we
depicted
atlas
IFS,
which
comprised
14
populations.
Through
comparison
with
normal
cells,
malignant
cells
distinguished,
potential
markers
(POSTN,
IGFBP2
CTHRC1)
identified.
also
found
various
functional
subtypes,
three
exhibited
cancer
stem
(CSCs)
phenotypes,
investigated
interplay
between
these
subtypes
nonmalignant
TME
Endothelial
macrophages
dominate
communication
landscape
within
microenvironment,
promoting
tumorigenesis
via
multiple
receptor-ligand
interactions.
Conclusions:
provides
comprehensive
characterization
transcriptome
cellular
level,
offering
valuable
insights
clinically
significant
advancements
treatment
Language: Английский